Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
pay-for-delay
Pharma
Pfizer ponies up $39M to resolve old pay-for-delay lawsuit
Pfizer and a class action group of direct drug purchasers have agreed to settle an antitrust, pay-for-delay claim for $39 million.
Kevin Dunleavy
Apr 11, 2024 11:00am
Another EpiPen antitrust settlement costs Pfizer $50M
Oct 11, 2023 6:03pm
Takeda settles antitrust lawsuit over gout drug Colcrys
Sep 21, 2023 10:55am
Gilead and Teva's HIV antitrust trial kicks off in California
May 25, 2023 9:20am
Merck, Glenmark settle part of Zetia pay-for-delay case
Apr 21, 2023 9:42am
Takeda hit with another pay-for-delay lawsuit
Apr 12, 2023 11:21am
